lysine has been researched along with Pseudomonas Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, S; Ansari, MM; Ghosh, JK; Mitra, K; Pant, G; Pratap Verma, D; Saroj, J; Singh, BN; Verma, NK | 1 |
| Brüschweiler, R; Bruschweiler-Li, L; Leggett, A; Li, DW; Rigel, N; Sindeldecker, D; Staats, A; Stoodley, P | 1 |
| Bilton, D; Downey, DG; Eustace, JA; Gunaratnam, C; Haworth, CS; Jones, AM; Ketchell, RI; McKone, EF; Peckham, DG; Plant, BJ | 1 |
| Damborg, P; Franzyk, H; Hansen, PR; Kłodzińska, SN; Molchanova, N; Nielsen, HM | 1 |
| Kirkpatrick, P; O'Sullivan, BP; Yasothan, U | 1 |
| Elborn, JS; Parkins, MD | 1 |
| Plosker, GL | 1 |
| Kralova, H; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Radermacher, P; Rokyta, R | 1 |
| Dziubak, ST | 1 |
| Fukuoka, T; Iijima, M; Katsuta, M; Masuda, N; Narita, T; Nikaido, H; Ohya, S; Trias, J; Yasuda, H | 1 |
| Greenberg, SS; Hua, L; Nelson, S; Ouyang, J; Wang, JF; Zhao, X | 1 |
2 review(s) available for lysine and Pseudomonas Infections
| Article | Year |
|---|---|
Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis.
Topics: Administration, Inhalation; Adult; Aerosols; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Lysine; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Treatment Outcome | 2010 |
Aztreonam lysine for inhalation solution: in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Lysine; Pharmaceutical Solutions; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
9 other study(ies) available for lysine and Pseudomonas Infections
| Article | Year |
|---|---|
Tandem Repeat of a Short Human Chemerin-Derived Peptide and Its Nontoxic d-Lysine-Containing Enantiomer Display Broad-Spectrum Antimicrobial and Antitubercular Activities.
Topics: Animals; Antimicrobial Peptides; Antitubercular Agents; Cell Survival; Chemokines; Dose-Response Relationship, Drug; Erythrocytes; Humans; Lysine; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship; THP-1 Cells | 2021 |
Cadaverine Is a Switch in the Lysine Degradation Pathway in
Topics: Anti-Bacterial Agents; Biofilms; Cadaverine; Humans; Lysine; Metabolomics; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Aztreonam; Body Mass Index; Cystic Fibrosis; Drug Monitoring; Female; Forced Expiratory Volume; Hospitalization; Humans; Lysine; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Treatment Outcome | 2017 |
Biopolymer nanogels improve antibacterial activity and safety profile of a novel lysine-based α-peptide/β-peptoid peptidomimetic.
Topics: Anti-Bacterial Agents; Biofilms; Biopolymers; Drug Carriers; Drug Compounding; Gels; Hepatocytes; Humans; Hyaluronic Acid; Lysine; Microbial Sensitivity Tests; Nanoparticles; Peptides; Peptidomimetics; Peptoids; Pseudomonas aeruginosa; Pseudomonas Infections; Succinic Anhydrides; Toxicity Tests | 2018 |
Inhaled aztreonam.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Drug Discovery; Humans; Lysine; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 2010 |
Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia--effects of selective inducible nitric oxide synthase inhibition.
Topics: Acid-Base Equilibrium; Animals; Bacteremia; Blood Coagulation; Cardiovascular System; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Fibrinogen; Lysine; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Pseudomonas aeruginosa; Pseudomonas Infections; Swine; Time Factors | 2007 |
[The effect of Pseudomonas aeruginosa exotoxin on various nonspecific factors of immunologic reactivity in an experiment].
Topics: Animals; Blood Bactericidal Activity; Complement System Proteins; Exotoxins; Immunity, Innate; Lysine; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1983 |
Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.
Topics: Animals; Ascitic Fluid; Bacterial Outer Membrane Proteins; Ceftazidime; Cell Membrane; Diffusion; Humans; Imipenem; Lysine; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Permeability; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1993 |
Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in vivo.
Topics: Animals; Corticosterone; Enzyme Induction; Enzyme Inhibitors; Ethanol; Lung; Lysine; Macrophages, Alveolar; Male; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Binding; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Stem Cells; Transcription, Genetic | 1999 |